AMENDMENT TO THE REGISTRATION RIGHTS AGREEMENTThe Registration Rights Agreement • January 22nd, 2018 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
This Amendment (this “Amendment”), dated as of January 21, 2018, is made by Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the persons listed on the attached Schedule A who are signatories to this Amendment (collectively, the “Investors”).
